Related Experiment Videos
Isolation in the allogeneic transplant environment: how protective is it?
B Hayes-Lattin1, J F Leis, R T Maziarz
1Center for Hematologic Malignancies, OHSU Cancer Institute, Oregon Health and Science University, Portland, OR 97239, USA. hayeslat@ohsu.edu
Bone Marrow Transplantation
|June 22, 2005
Summary
Aggressive infection control measures during allogeneic stem cell transplantation (SCT) are standard but lack proven benefit and incur costs. Practices are being reconsidered due to outpatient SCT trials and cost containment.
Area of Science:
- Hematology
- Infectious Diseases
- Hospital Administration
Background:
- Aggressive infection control measures, including protective isolation, are standard in allogeneic stem cell transplantation (SCT).
- These measures encompass ventilation, unit design, barrier precautions, patient care, and infection surveillance.
- The efficacy and cost-effectiveness of many of these interventions are not definitively established.
Purpose of the Study:
- To evaluate the necessity and efficacy of current infection control practices in allogeneic SCT.
- To inform the reconsideration of established protocols in managing the transplant environment.
Main Methods:
- Review of existing literature and clinical trial data on infection control in SCT.
- Analysis of the financial and social costs associated with intensive isolation protocols.
- Consideration of emerging trends, such as outpatient SCT and cost containment initiatives.
Main Results:
- Many infection control practices lack definitive proof of improved patient outcomes (reduced infection rates or enhanced survival).
- Intensive isolation protocols involve significant financial and social costs.
- Recent trials suggest the feasibility of safe outpatient care post-allogeneic SCT.
Conclusions:
- Transplant teams should critically reassess current infection control practices in allogeneic SCT.
- Local infection patterns and communication with infection control committees are crucial for adapting isolation strategies.
- The evolving landscape of SCT care necessitates a re-evaluation of environmental controls for immunosuppressed patients.